Top 20 Transave investors
The most complete profiles first. Showing 20 of 20.
Antoine BoulangerVerified
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Anastasia KarpovaVerified
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Charles HughesVerified
Micro VC · United States
Health CareWearablesHospitalsCybersecurityPortfolio: Catalyst Biosciences, Wirecom Technologies, Kit Check, Sonics and 37 more
Verified email available
David SchnellVerified
Venture Capital · United States
Health CareWearablesGeneticsBiotechnologyPortfolio: Rejuvenon, Gloucester Pharmaceuticals, Visiogen, NGM Biopharmaceuticals and 40 more
Verified email available
Francisco GarciaVerified
Micro VC · United States
Health CareWearablesHospitalsCybersecurityPortfolio: Catalyst Biosciences, Wirecom Technologies, Kit Check, Sonics and 37 more
Verified email available
John FriedmanVerified
Venture Capital, Private Equity Firm, Micro VC · United States
Health CareWearablesHospitalsCybersecurityPortfolio: Catalyst Biosciences, Wirecom Technologies, Kit Check, Sonics and 37 more
Verified email available
John MontanaVerified
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Geert
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Holger Reithinger
Venture Capital, Investor · Germany
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Juliette Audet
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Martien van Osch
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Rogier Rooswinkel
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Wouter Joustra
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Asiya Giniatullina
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Bonnie van Wilgenburg
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Carlo Incerti
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Russell Hirsch
Venture Capital · United States
Health CareWearablesGeneticsBiotechnologyPortfolio: Rejuvenon, Gloucester Pharmaceuticals, Visiogen, NGM Biopharmaceuticals and 40 more
Contact details available
Sander van Deventer
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Ting Pau Oei
Micro VC · United States
Health CareWearablesHospitalsCybersecurityPortfolio: Catalyst Biosciences, Wirecom Technologies, Kit Check, Sonics and 37 more
Contact details available
Vincent van Houten
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Frequently asked questions
How many Transave investors are on Angel Roster?
Angel Roster lists 20 Transave investors. 7 of them (35%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (7) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Transave investors invest in?
Among those that list a stage, the most common are Seed (7).
Where are Transave investors based?
Most are based in the Netherlands (12), the United States (6) and Germany (1).
Which companies have Transave investors backed?
The most-backed portfolio companies among them are Bluebird Bio (18), Promedior (18), Acorda Therapeutics (18), Prilenia (14) and Cardoz (14).
How do I contact Transave investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.